France Steps Up National Fertility Plan: Information Campaigns, Expanded Access, and Future Reforms for 2027

The French government has unveiled the latest developments in its comprehensive national fertility plan, marking a significant shift from prolonged administrative delays into active public health policy. Presented on Tuesday following the delivery of a steering committee report, the updated strategy encompasses targeted information campaigns, modernized communication channels for young adults, and an expansion of medical infrastructure aimed at addressing infertility—an issue affecting more than three million people in France. While the current announcements focus heavily on prevention and education, authorities have signaled that more profound legislative and systemic measures will follow ahead of a full plan update in early 2027.

Background Context and Political Origins

The journey toward a structured national fertility strategy has been politically fraught and protracted. Promised more than two years ago by President Emmanuel Macron, the initiative was initially shadowed by controversy. When the concept was formally announced in February, it immediately drew sharp criticism from feminist organizations and civil society groups. The primary point of contention was the administration’s framing of the initiative around the concept of "demographic rearmament," a phrase used by the president to express concern over declining birth rates in France. Critics argued that linking public health measures regarding reproductive biology directly to state demographic goals felt coercive and placed undue pressure on individuals regarding their private family planning decisions.

In response to these criticisms and broader concerns from healthcare professionals who deemed the initial proposals intrusive or infantalizing, the government returned to the drawing board. The revised approach places less emphasis on state-directed demographic imperatives and pivots more sharply toward individual health literacy, reproductive autonomy, and timely medical intervention.

Chronology of the New Information Campaigns and Outreach

Recognizing that public awareness regarding the biological realities of aging and fertility remains critically low, the government is rolling out a multi-tiered communication strategy. According to Health Minister Stéphanie Rist, too many citizens are simply not informed about fertility preservation and reproductive health at the age when such knowledge is most useful.

Beginning immediately, the Ministry of Health, in collaboration with public health agency Santé Publique France, has launched the country’s first national information campaign dedicated to fertility. Targeted specifically at men and women between the ages of 20 and 35—regardless of their immediate parental intentions—the campaign seeks to educate the public on the various lifestyle, biological, and environmental factors that influence reproductive capacity.

For younger demographics, specifically those aged 18 to 25, fertility discussions are being formally integrated into "Mon Bilan Prévention," a series of preventative health consultations fully covered by the national social security system.

Meanwhile, the controversial plan to directly notify citizens via digital mailboxes has also been modified. Rather than receiving a standalone letter at age 29 that critics feared might feel overly prescriptive, French citizens turning 29 will now receive a standardized informational notice via the official Assurance Maladie (health insurance) online portal by the end of November. This communication is designed strictly to inform individuals about the general mechanics of fertility, age-related decline, and the existing possibilities for fertility preservation within the French healthcare system.

Expanding Medical Infrastructure and Reducing Wait Times

Beyond communication, a core pillar of the government’s strategy involves expanding physical access to medical procedures, most notably oocyte (egg) cryopreservation. The surge in demand for Medically Assisted Procreation (MAP, or PMA in French) has accelerated dramatically since the landmark 2021 bioethics law opened access to all women, including single women and lesbian couples. This surge severely strained existing medical infrastructure, resulting in protracted waiting lists that sometimes exceeded a year and prompting some prospective parents to seek costly treatments abroad.

In response, the government announced in February an ambitious goal to authorize dozens of new centers for egg freezing by 2028. Delivering on an interim milestone, Health Minister Rist confirmed on Tuesday that 30 new centers have successfully been deployed, bringing the total number of authorized establishments nationwide to 70.

Despite this expansion, the system remains under heavy strain. Rist acknowledged that average waiting times have decreased by a modest 1.3 months, but emphasized that the current duration remains "too long" given the biological urgency associated with age-related fertility loss.

To accelerate relief, the steering committee report—co-authored by Professor Samir Hamamah and author Salomé Berlioux—has strongly recommended opening the authorization for oocyte cryopreservation to all public and private MAP centers, which would effectively double the network to roughly 100 facilities across the country. Signaling a major departure from traditional French healthcare boundaries, Minister Rist stated that she is entirely open to exploring cooperation with for-profit private clinics, noting that a relevant amendment could be introduced during upcoming debates on the Social Security financing bill. Additional recommendations from the report include creating a national management system to better pool and allocate gamete stocks and streamlining diagnostic and therapeutic patient pathways.

Stakeholder Reactions and Calls for a Paradigm Shift

The presentation of the report has elicited a mixture of cautious optimism and demands for further, more radical reforms from medical professionals and patient advocacy groups.

Professor Hamamah, addressing the health minister during Tuesday’s presentation, declared that the nation has successfully moved past societal taboos and entered a phase of tangible action. Reflecting on the prolonged rollout of the strategy, he attributed the delays to the extreme sensitivity of the topic and the political instability following the dissolution of the National Assembly.

However, patient advocates emphasize that much work remains. Virginie Rio, co-founder of the Bamp collective—an association representing infertile individuals and those navigating MAP processes—insisted that real-world implementation must accelerate rapidly. Rio called for a fundamental psychological and cultural shift in how society approaches assisted reproduction. "We need to change the paradigm," she stated. "We talk about MAP as a battle parcours, and that has to stop. We are not going to war; we are simply trying to have children."

To truly alleviate the burden on patients, advocacy groups and several political figures argue that broader diagnostic tools must be integrated into the standard healthcare framework. A prominent proposal involves legalizing Pre-Implantation Genetic Testing for Aneuploidies (PGT-A), a procedure that allows clinicians to screen embryos for chromosomal abnormalities before implantation, thereby reducing miscarriage rates and failed implantations. This measure is currently backed by a cross-party coalition of lawmakers led by Deputy Constance de Pélichy, as well as political figures like environmentalist leader Marine Tondelier.

While Minister Rist has indicated she is personally open to considering PGT-A "under certain conditions and for specific profiles," she noted that any such decision would require rigorous preliminary recommendations from the National Ethics Committee.

Broader Socioeconomic Implications and Future Outlook

The systemic challenges surrounding fertility extend far beyond clinical infrastructure and medical interventions. Recognizing that declining birth rates and involuntary childlessness are deeply intertwined with broader socioeconomic conditions, the Economic, Social, and Environmental Council (CESE)—at the request of National Assembly President Yaël Braun-Pivet—is currently compiling a complementary analytical report. According to CESE President Claire Thoury, this upcoming study will examine the phenomenon of the "thwarted desire for a child," analyzing all the systemic barriers that obstruct family planning, including precarious living conditions, housing shortages, employment instability, environmental pollutants, and inadequate workplace support.

As the Ministry of Health embarks on a new phase of interministerial work to translate the steering committee’s recommendations into binding legislative measures, the ultimate deadline for the updated national fertility plan is set for early 2027. Coming just ahead of the next presidential election, the finalized framework will serve as a crucial test of the government’s ability to transform high-level public health ambitions into accessible, timely, and empathetic care for families across France.